Results 171 to 180 of about 53,085 (229)

Efficacy and Safety of Daratumumab-Based Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. [PDF]

EJHaem
Khan AM, Ajmal H, Khalid M, Babar W, Shafaqat U, Fida T, Hassan MA, Fatima S, Akram AS, Segawa F.   +9 more
europepmc   +1 more source

The 19S proteasome as a therapeutic target in hematologic malignancies. [PDF]

Front Cell Dev Biol
Olivas IM, Gonzalez-Henry MA, Darvishi S, Esparza EM, Eiring AM.   +4 more
europepmc   +1 more source

Development and validation of a specific method for the detection and quantification of Bortezomib in the prepared Bortezomib bovine serum albumin nanoparticles

Areej Wahhab Alhagiesa, Mowafaq Mohammed Ghareeb   +1 more
openalex   +2 more sources

Lenalidomide-Associated Rhabdomyolysis Progressing to Bilateral Compartment Syndrome and Permanent Foot Drop. [PDF]

Case Rep Oncol Med
Iyer K, Chetan S, Arkala A, Siegel CS, Gadi B, Popu C, Oke V, Cadiz BS.   +7 more
europepmc   +1 more source

Non-coding RNAs as predictive factors of oncological outcomes in plasma cell myeloma. [PDF]

Oncol Rev
Bogdanowicz-Żeleźniak A, Moniczewska N, Korpysz M, Szudy-Szczyrek A, Mlak R.   +4 more
europepmc   +1 more source

Ruxolitinib inhibits CaMKII-γ to reverse bortezomib resistance in multiple myeloma. [PDF]

Commun Biol
Liang R, Liu H, Zhong X, Chen Y, Tian J, Zhang C, Wang M.   +6 more
europepmc   +1 more source

A selective inhibitor reveals roles for LONP1 in mitochondrial proteostasis and OXPHOS dependencies. [PDF]

Life Sci Alliance
Szilagyi Z, Michon P, Pardo-Hernández C, Sãcultanu M, Miralles Fusté J, Griffin AM, Charifson PS, Phan C, Shi Y, Kern G, Martinez Botella G, Keating TA, Macao B, Larsson NG, Falkenberg M, Green J, Gustafsson CM.   +16 more
europepmc   +1 more source

Noncrystalline light-chain proximal tubulopathy: a retrospective study from a single institute of China. [PDF]

Ren Fail
Yao JQ, Wang YH, Zhang X, Wang SX, Yang L, Zhou FD, Zhao MH, Yu XJ.   +7 more
europepmc   +1 more source

Bortezomib in Patients Who Fail BTKi in Waldenström Macroglobulinaemia. [PDF]

Hematol Rep
Khwaja J, Japzon N, Gatto S, Lindsay J, Kyriakou C, D'Sa S.   +5 more
europepmc   +1 more source